Stay informed with null’s coverage and analysis for Fortune.

Page 19 of 40

  • Photo of Elon MuskTech

    Elon Musk’s brain-implant startup Neuralink may have misled regulators about Musk’s leadership role

    By
  • 13 August 2021, Brandenburg, Grünheide: Elon Musk, Tesla CEO, stands at a press event on the grounds of the Tesla Gigafactory. The first vehicles are to roll off the production line in Grünheide near Berlin from the end of 2021. The US company plans to build around 500,000 units of the compact Model 3 and Model Y series here each year. Photo: Patrick Pleul/dpa-Zentralbild/ZB (Photo by Patrick Pleul/picture alliance via Getty Images)Tech

    Neuralink’s leader suddenly departed last year. Employees say his relationship with founder Elon Musk had long felt strained

    By Jeremy Kahn and Jonathan Vanian
  • Elon Musk, chief executive officer of Tesla Inc., left, departs court during the SolarCity trial in Wilmington, Delaware, U.S., on Tuesday, July 13, 2021. Musk was cool but combative as he testified in a Delaware courtroom that Tesla’s more than $2 billion acquisition of SolarCity in 2016 wasn’t a bailout of the struggling solar provider. Photographer: Al Drago/Bloomberg via Getty ImagesTech

    Neuralink former employees say Elon Musk applies relentless pressure and instills a culture of blame

    By Jeremy Kahn and Jonathan Vanian
  • Photo of OpenAI CEO Sam AltmanNewsletters

    OpenAI says its making progress on “The Alignment Problem”

    By
  • MIND-CHANGERS Elon Musk alongside the R1, the surgical robot Neuralink developed to implant its brain-computer interface devices. Musk has convinced Silicon Valley that BCIs are an investable business—though many argue he has exaggerated what they can do.<br /> Courtesy of Card79Magazine

    Inside Neuralink, Elon Musk’s mysterious brain chip startup: A culture of blame, impossible deadlines, and a missing CEO

    By Jeremy Kahn and Jonathan Vanian
  • Photo of Julie SweetTech

    CEOs of America’s biggest companies detail how to achieve ‘responsible A.I.’

    By
  • Bristol-Myers Squibb logo on a smartphoneNewsletters

    What a Bristol-Myers project to monitor off-label prescribing says about future uses of A.I.

    By Jeremy Kahn and Jonathan Vanian
  • Structural images of the main COVID-19 virus variants from Alpha to Omicron.Health

    BioNTech and London A.I. firm create ‘early warning system’ to spot dangerous new COVID-19 variants before they spread

    By
  • Photo of gloves being inspected by human workers at a rubber glove manufacturing plant in China.Newsletters

    At Google Cloud, A.I. ethics requires ‘Iced Tea’ and ‘Lemonaid’

    By
  • Gloved hand holding pills in front of Sanofi corporate logoHealth

    Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion

    By
  • Photo of Dr. Mike Ryan, WHO health emergencies program director.Health

    WHO to world: Don’t be so confident that Omicron is less dangerous

    By
  • Photo illustration of a syringe jabbing a stock chart that shows shares rising and then fallingFinance

    Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?

    By
  • Sign saying that customers must wear masks when not seated at the table at a restaurant in WalesHealth

    Is Omicron the beginning of the end-emic? Some countries ease COVID restrictions even as infections surge

    By
  • Photo of Jack Dorsey.Tech

    Web3 fans and venture investors return fire after Jack Dorsey’s disparaging tweet

    By
  • Photo of attack drones that have been called ”killer robots.”Tech

    The world just blew a ‘historic opportunity’ to stop killer robots—and that might be a good thing

    By